169 related articles for article (PubMed ID: 29099465)
1. Management of Chronic Hepatitis C in End-stage Renal Disease.
Angulo-Diaz V; Lim JK; Martin P; Liapakis A
J Clin Gastroenterol; 2018 Apr; 52(4):287-294. PubMed ID: 29099465
[TBL] [Abstract][Full Text] [Related]
2. 'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.
García-Agudo R; Aoufi-Rabih S; Salgueira-Lazo M; González-Corvillo C; Fabrizi F
Int J Artif Organs; 2018 Jul; 41(7):363-370. PubMed ID: 29582685
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.
Bhamidimarri KR; Ladino M; Pedraza F; Guerra G; Mattiazzi A; Chen L; Ciancio G; Kupin W; Martin P; Burke G; Roth D
Transpl Int; 2017 Sep; 30(9):865-873. PubMed ID: 28332729
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Chronic Hepatitis C in Special Populations.
Bunchorntavakul C; Tanwandee T
Gastroenterol Clin North Am; 2015 Dec; 44(4):883-900. PubMed ID: 26600226
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus infection in end-stage renal disease and kidney transplantation.
Burra P; Rodríguez-Castro KI; Marchini F; Bonfante L; Furian L; Ferrarese A; Zanetto A; Germani G; Russo FP; Senzolo M
Transpl Int; 2014 Sep; 27(9):877-91. PubMed ID: 24853721
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
Lin MV; Sise ME; Pavlakis M; Amundsen BM; Chute D; Rutherford AE; Chung RT; Curry MP; Hanifi JM; Gabardi S; Chandraker A; Heher EC; Elias N; Riella LV
PLoS One; 2016; 11(7):e0158431. PubMed ID: 27415632
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic viral hepatitis in patients with renal disease.
Fabrizi F; Martin P; Bunnapradist S
Gastroenterol Clin North Am; 2004 Sep; 33(3):655-70, xi. PubMed ID: 15324949
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology and Treatment of Hepatitis B and C Infections in Patients With End-Stage Renal Disease.
Soi V; Daifi C; Yee J; Adams E
Adv Chronic Kidney Dis; 2019 Jan; 26(1):41-50. PubMed ID: 30876616
[TBL] [Abstract][Full Text] [Related]
9. Reversal of end-stage renal failure using direct-acting antiviral agents for chronic hepatitis C.
Mitchell T; Chakera A; Jeffrey GP; Adams LA; Garas G; Jones T; MacQuillan G
Med J Aust; 2016 Sep; 205(5):205-6. PubMed ID: 27581262
[No Abstract] [Full Text] [Related]
10. New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
Fabrizi F; Martin P; Messa P
Kidney Int; 2016 May; 89(5):988-994. PubMed ID: 27083277
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection and chronic kidney disease: Time for reappraisal.
Cacoub P; Desbois AC; Isnard-Bagnis C; Rocatello D; Ferri C
J Hepatol; 2016 Oct; 65(1 Suppl):S82-S94. PubMed ID: 27641990
[TBL] [Abstract][Full Text] [Related]
12. Chronic hepatitis C and chronic kidney disease: Advances, limitations and unchartered territories.
Mendizabal M; Reddy KR
J Viral Hepat; 2017 Jun; 24(6):442-453. PubMed ID: 28107583
[TBL] [Abstract][Full Text] [Related]
13. HCV and the kidney.
Corouge M; Vallet-Pichard A; Pol S
Liver Int; 2016 Jan; 36 Suppl 1():28-33. PubMed ID: 26725894
[TBL] [Abstract][Full Text] [Related]
14. Comment on "Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience".
Li X; Lou L
Rev Assoc Med Bras (1992); 2021 Jun; 67(6):909. PubMed ID: 34709345
[No Abstract] [Full Text] [Related]
15. Current therapies for chronic hepatitis C.
Ferguson MC
Pharmacotherapy; 2011 Jan; 31(1):92-111. PubMed ID: 21182362
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus-positive patients on the waiting list for transplantation.
Campistol JM; Esforzado N; Morales JM
Semin Nephrol; 2002 Jul; 22(4):361-4. PubMed ID: 12118401
[TBL] [Abstract][Full Text] [Related]
17. Kidney Transplants for Patients With Hepatitis C Virus Infection.
Ann Intern Med; 2018 Aug; 169(4):. PubMed ID: 29987320
[No Abstract] [Full Text] [Related]
18. HIV and HCV Medications in End-Stage Renal Disease.
Greenberg KI; Perazella MA; Atta MG
Semin Dial; 2015; 28(4):397-403. PubMed ID: 25845407
[TBL] [Abstract][Full Text] [Related]
19. Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantation.
Knapstein J; Galle PR; Zimmermann T
Dig Liver Dis; 2014 Jan; 46(1):88-9. PubMed ID: 24054768
[No Abstract] [Full Text] [Related]
20. Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis.
Toyoda H; Kumada T; Tada T; Takaguchi K; Ishikawa T; Tsuji K; Zeniya M; Iio E; Tanaka Y
J Gastroenterol; 2016 Jul; 51(7):741-7. PubMed ID: 26872889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
